ENLV icon

Enlivex Therapeutics
ENLV

Overview Fund Activity

21 hedge funds and large institutions have $2.87M invested in Enlivex Therapeutics in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 8 reducing their positions, and 7 closing their positions.

Holders
21
Holders Change
-5
Holders Change %
-19.23%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
8
Closed
7
Calls
$101K
Puts
$8K
Net Calls
+$93K
Net Calls Change
+$55K

Top Buyers

1
Group One Trading
1
Group One Trading
Illinois
$7.84K
2
Bank of America
2
Bank of America
North Carolina
$3.41K
3
SWM
3
Spire Wealth Management
Virginia
$560
4
Raymond James Financial
4
Raymond James Financial
Florida
$64

Top Sellers

1
AC
1
Armistice Capital
New York
$1.58M
2
Citadel Advisors
2
Citadel Advisors
Florida
$0
3
Millennium Management
3
Millennium Management
New York
$686K
4
TSS
4
Two Sigma Securities
New York
$0
5
Jane Street
5
Jane Street
New York
$68.4K
Name Market Value Shares Shares
Change 		Shares
Change %
HF
26
HRT Financial
New York
– – -10,178 Closed
Simplex Trading
27
Simplex Trading
Illinois
– – -1,063 Closed
UBS Group
28
UBS Group
Switzerland
– – -16 Closed
1
2